Isoform-specific Characterization of Class I Histone Deacetylases and Their Therapeutic Modulation in Pulmonary Hypertension

Overview

Journal Sci Rep

Specialty Science

Date 2020 Aug 1

PMID 32733053

Citations 19

Authors

Prakash Chelladurai

Swati Dabral

Sobha Rani Basineni

Chien-Nien Chen

Mario Schmoranzer

Nina Bender

Christine Feld

Rene Reiner Notzold

Gergana Dobreva

Jochen Wilhelm

Benno Jungblut

Lan Zhao

Uta-Maria Bauer

Werner Seeger

Soni Savai Pullamsetti

Affiliations

Soon will be listed here.

Abstract

Pharmacological modulation of class I histone deacetylases (HDAC) has been evaluated as a therapeutic strategy for pulmonary hypertension (PH) in experimental models of PH. However, information of their expression, regulation and transcriptional targets in human PH and the therapeutic potential of isoform-selective enzyme modulation are lacking. Comprehensive analysis of expression and regulation of class I HDACs (HDAC1, HDAC2, HDAC3 and HDAC8) was performed in cardiopulmonary tissues and adventitial fibroblasts isolated from pulmonary arteries (PAAF) of idiopathic pulmonary arterial hypertension (IPAH) patients and healthy donors. Cellular functions and transcriptional targets of HDAC enzymes were investigated. Therapeutic effects of pan-HDAC (Vorinostat), class-selective (VPA) and isoform-selective (CAY10398, Romidepsin, PCI34051) HDAC inhibitors were evaluated ex vivo (IPAH-PAAF, IPAH-PASMC) and in vivo (rat chronic hypoxia-induced PH and zebrafish angiogenesis). Our screening identifies dysregulation of class I HDAC isoforms in IPAH. Particularly, HDAC1 and HDAC8 were consistently increased in IPAH-PAs and IPAH-PAAFs, whereas HDAC2 and HDAC8 showed predominant localization with ACTA2-expressing cells in extensively remodeled IPAH-PAs. Hypoxia not only significantly modulated protein levels of deacetylase (HDAC8), but also significantly caused dynamic changes in the global histone lysine acetylation levels (H3K4ac, H3K9/K14ac and H3K27ac). Importantly, isoform-specific RNA-interference revealed that HDAC isoforms regulate distinct subset of transcriptome in IPAH-PAAFs. Reduced transcript levels of KLF2 in IPAH-PAAFs was augmented by HDAC8 siRNA and HDAC inhibitors, which also attenuated IPAH-associated hyperproliferation and apoptosis-resistance ex vivo, and mitigated chronic hypoxia-induced established PH in vivo, at variable degree. Class I HDAC isoforms are significantly dysregulated in human PAH. Isoform-selective HDAC inhibition is a viable approach to circumvent off-target effects.

Citing Articles

Pulmonary Hypertension: Molecular Mechanisms and Clinical Studies.

Adu-Amankwaah J, You Q, Liu X, Jiang J, Yang D, Liu K MedComm (2020). 2025; 6(3):e70134.

PMID: 40066229 PMC: 11892029. DOI: 10.1002/mco2.70134.

Right Ventricular Hypertrophy in Spontaneously Hypertensive Rats (SHR/NHsd) Is Associated with Inter-Individual Variations of the Pulmonary Endothelin System.

Langer A, Schreckenberg R, Schluter K Biology (Basel). 2024; 13(10).

PMID: 39452062 PMC: 11505455. DOI: 10.3390/biology13100752.

Role of histone deacetylase inhibitors in non-neoplastic diseases.

Zhou C, Zhao D, Wu C, Wu Z, Zhang W, Chen S Heliyon. 2024; 10(13):e33997.

PMID: 39071622 PMC: 11283006. DOI: 10.1016/j.heliyon.2024.e33997.

Fibroblasts in Pulmonary Hypertension: Roles and Molecular Mechanisms.

Zhang H, Li M, Hu C, Stenmark K Cells. 2024; 13(11.

PMID: 38891046 PMC: 11171669. DOI: 10.3390/cells13110914.

Epigenetic modification: A novel insight into diabetic wound healing.

Ju C, Liu X, Liu L, Guo N, Guan L, Wu J Heliyon. 2024; 10(6):e28086.

PMID: 38533007 PMC: 10963386. DOI: 10.1016/j.heliyon.2024.e28086.

References

Kim J, Lee A, Choi J, Park Y, Kang H, Chang W . Epigenetic modulation as a therapeutic approach for pulmonary arterial hypertension. Exp Mol Med. 2015; 47:e175. PMC: 4525299. DOI: 10.1038/emm.2015.45. View

Lalonde M, Cheng X, Cote J . Histone target selection within chromatin: an exemplary case of teamwork. Genes Dev. 2014; 28(10):1029-41. PMC: 4035532. DOI: 10.1101/gad.236331.113. View

Bannister A, Kouzarides T . Regulation of chromatin by histone modifications. Cell Res. 2011; 21(3):381-95. PMC: 3193420. DOI: 10.1038/cr.2011.22. View

Peserico A, Simone C . Physical and functional HAT/HDAC interplay regulates protein acetylation balance. J Biomed Biotechnol. 2010; 2011:371832. PMC: 2997516. DOI: 10.1155/2011/371832. View

Rosa-Garrido M, Chapski D, Vondriska T . Epigenomes in Cardiovascular Disease. Circ Res. 2018; 122(11):1586-1607. PMC: 5976233. DOI: 10.1161/CIRCRESAHA.118.311597. View

Haberland M, Montgomery R, Olson E . The many roles of histone deacetylases in development and physiology: implications for disease and therapy. Nat Rev Genet. 2008; 10(1):32-42. PMC: 3215088. DOI: 10.1038/nrg2485. View

Wang Y, Yan L, Zhang Z, Prado E, Fu L, Xu X . Epigenetic Regulation and Its Therapeutic Potential in Pulmonary Hypertension. Front Pharmacol. 2018; 9:241. PMC: 5870037. DOI: 10.3389/fphar.2018.00241. View

Li M, Riddle S, Frid M, El Kasmi K, McKinsey T, Sokol R . Emergence of fibroblasts with a proinflammatory epigenetically altered phenotype in severe hypoxic pulmonary hypertension. J Immunol. 2011; 187(5):2711-22. PMC: 3159707. DOI: 10.4049/jimmunol.1100479. View

Zhao L, Chen C, Hajji N, Oliver E, Cotroneo E, Wharton J . Histone deacetylation inhibition in pulmonary hypertension: therapeutic potential of valproic acid and suberoylanilide hydroxamic acid. Circulation. 2012; 126(4):455-67. PMC: 3799888. DOI: 10.1161/CIRCULATIONAHA.112.103176. View

10.

Wang Z, Zang C, Cui K, Schones D, Barski A, Peng W . Genome-wide mapping of HATs and HDACs reveals distinct functions in active and inactive genes. Cell. 2009; 138(5):1019-31. PMC: 2750862. DOI: 10.1016/j.cell.2009.06.049. View

11.

Greer C, Tanaka Y, Kim Y, Xie P, Zhang M, Park I . Histone Deacetylases Positively Regulate Transcription through the Elongation Machinery. Cell Rep. 2015; 13(7):1444-1455. PMC: 4934896. DOI: 10.1016/j.celrep.2015.10.013. View

12.

Santiago L, Daniels G, Wang D, Deng F, Lee P . Wnt signaling pathway protein LEF1 in cancer, as a biomarker for prognosis and a target for treatment. Am J Cancer Res. 2017; 7(6):1389-1406. PMC: 5489786. View

13.

Chandra S, Razavi H, Kim J, Agrawal R, Kundu R, De Jesus Perez V . Disruption of the apelin-APJ system worsens hypoxia-induced pulmonary hypertension. Arterioscler Thromb Vasc Biol. 2011; 31(4):814-20. PMC: 3113525. DOI: 10.1161/ATVBAHA.110.219980. View

14.

Bogaard H, Mizuno S, Hussaini A, Toldo S, Abbate A, Kraskauskas D . Suppression of histone deacetylases worsens right ventricular dysfunction after pulmonary artery banding in rats. Am J Respir Crit Care Med. 2011; 183(10):1402-10. DOI: 10.1164/rccm.201007-1106OC. View

15.

Gurvich N, Berman M, Wittner B, Gentleman R, Klein P, Green J . Association of valproate-induced teratogenesis with histone deacetylase inhibition in vivo. FASEB J. 2005; 19(9):1166-8. DOI: 10.1096/fj.04-3425fje. View

16.

Reyes-Palomares A, Gu M, Grubert F, Berest I, Sa S, Kasowski M . Remodeling of active endothelial enhancers is associated with aberrant gene-regulatory networks in pulmonary arterial hypertension. Nat Commun. 2020; 11(1):1673. PMC: 7125148. DOI: 10.1038/s41467-020-15463-x. View

17.

Waltregny D, Glenisson W, Tran S, North B, Verdin E, Colige A . Histone deacetylase HDAC8 associates with smooth muscle alpha-actin and is essential for smooth muscle cell contractility. FASEB J. 2005; 19(8):966-8. DOI: 10.1096/fj.04-2303fje. View

18.

Trivedi C, Luo Y, Yin Z, Zhang M, Zhu W, Wang T . Hdac2 regulates the cardiac hypertrophic response by modulating Gsk3 beta activity. Nat Med. 2007; 13(3):324-31. DOI: 10.1038/nm1552. View

19.

Kee H, Eom G, Joung H, Shin S, Kim J, Cho Y . Activation of histone deacetylase 2 by inducible heat shock protein 70 in cardiac hypertrophy. Circ Res. 2008; 103(11):1259-69. DOI: 10.1161/01.RES.0000338570.27156.84. View

20.

Karmodiya K, Krebs A, Oulad-Abdelghani M, Kimura H, Tora L . H3K9 and H3K14 acetylation co-occur at many gene regulatory elements, while H3K14ac marks a subset of inactive inducible promoters in mouse embryonic stem cells. BMC Genomics. 2012; 13:424. PMC: 3473242. DOI: 10.1186/1471-2164-13-424. View